Positive age beliefs associated with resisting dementia among participants with <i>APOE</i> ε4 and all participants.

<p>Dementia incidence was assessed over 4 years and adjusted for covariates among participants who were dementia-free at baseline. The symbol * indicates significant difference at p < .05 between those with positive and negative age beliefs among participants with <i>APOE</i> ε4 and among all participants. Age-belief scores were dichotomized at the mean of 15.</p

Consort Flow Diagram.

<p>Consort Flow Diagram.</p

Neuropsychological Tests: TMT at Study Entry.

<p>Neuropsychological Tests: TMT at Study Entry.</p

Neuropsychological Tests: COWA and Animal Naming at Study Entry.

<p>Neuropsychological Tests: COWA and Animal Naming at Study Entry.</p

Study Group Characteristics.

†<p>include vehicle dimensions (74/81 participants) and IED distance.</p>‡<p>Greater variance reflects the random inclusion of the two oldest individuals in the study population.</p

Neuropsychological Tests: COWA and Animal Naming at Day 7.

<p>Neuropsychological Tests: COWA and Animal Naming at Day 7.</p

Treatment Effects: Day 7 Symptoms.

*<p>95% Confidence Interval.</p

Unresolved mTBI Symptom Patterns on Treatment Day 7.

<p>Unresolved mTBI Symptom Patterns on Treatment Day 7.</p

Neuropsychological tests: TMT at Day 7.

*<p>p<0.05 or **p<0.01 by z-test versus TMTA (23.7±7.8 seconds (S.D.)) or TMTB.</p

Distribution of mTBI Symptoms Co-morbid with Balance Dysfunction: Entry to Study.

<p>Distribution of mTBI Symptoms Co-morbid with Balance Dysfunction: Entry to Study.</p